Showing results for: geny średniego ryzyka   Total: 9

  1. Lung cancer – genetic predisposition - panel (NOD2, P16, P53 - 1 mutation, CYP1B1)

    Analysis consists of a testing for the mutations in NOD2, P16, P53, and CYP1B1 genes, which …

    czytaj więcej »
  2. Ovarian cancer, genetic predisposition - panel (CHEK2, NOD2, CYP1B1)

    Analysis consists of a testing for the mutations in CHEK2, CYP1B1, and NOD2 genes, which inc…

    czytaj więcej »
  3. Prostate cancer – genetic predisposition - panel (CHEK2 - 4 mutations, BRCA1, NBS1)

    Analysis consists of a testing for the mutations in CHEK2, BRCA1, and NBS1 genes, which incr…

    czytaj więcej »
  4. Colorectal cancer, genetic predisposition – panel (CHEK2, NOD2, P16)

    Analysis consists of a testing for the mutations in CDKN2A, CHEK2, and NOD2 genes, which inc…

    czytaj więcej »
  5. Polymorphism C5972T in the BRCA2 gene

    Familial susceptibility to breast cancer

    czytaj więcej »
  6. Cyp1B1 –breast/ovarian cancer susceptibility to (C142G, G355T, G4326C)

    Determination of the presence of homozygotic variants in the Cyp1B1 gene (142 G/G, 355T/T, 4326C/C).

    czytaj więcej »
  7. Breast/ovarian/prostate cancer – susceptibility to (NBS1 657del5)

    Analysis of the presence of 657del5 variant in the NBS1 gene

    czytaj więcej »
  8. Melanoma, lung, colon cancer – susceptibility to (CDKN2A (p16)

    predisposition to CDKN2A

    czytaj więcej »
  9. Breast, ovarian , colorectal, prostate gland, renal carcinoma, thymus gland carcinoma- susceptibility to -CHEK2 ((1100delC, IVS2+1GA, I157T)

    Test determines the presence of 1100delC, IVS2+1GA, I157T alleles in the CHEK2 gene

    czytaj więcej »